ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,723, issued on Aug. 25, was assigned to AIM ImmunoTech Inc. (Ocala, Fla.).
"Compositions and methods for cancer therapy" was invented by David R. Strayer (Ocala, Fla.) and Thomas K. Equels (Ocala, Fla.).
According to the abstract* released by the U.S. Patent & Trademark Office: "One aspect of this disclosure is directed to a method for treating a cancer in a subject in need thereof by administering to the subject at least a first compound and a second compound in any order together or separately. The first compound is an effective amount of a checkpoint inhibitor optionally with at least one pharmaceutically acceptable carrier. The second compound is an effective amount of an The...